Physician profile
Ralph L Kramer
NPI 1235136920
$2,881.49
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $790 · 2021: $1,045 · 2022: $523.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $470.19 | 2020-2022 | |
| Novo Nordisk INC | $311.16 | 2019-2022 | |
| Allergan, INC. | $255.99 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $249.23 | 2019-2022 | |
| Amgen INC. | $146.68 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $127.82 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $122.94 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $109.37 | 2019-2022 | |
| Eisai INC. | $99.45 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $92.99 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $87.84 | 2019-2021 | |
| Glaxosmithkline, LLC. | $84.63 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.11 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $65.69 | 2021 | |
| Merck Sharp & Dohme LLC | $63.72 | 2020-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $60.69 | 2021-2022 | |
| Pfizer INC. | $57.19 | 2019-2022 | |
| Biogen, INC. | $50.26 | 2021 | |
| Astellas Pharma US INC | $41.01 | 2020-2021 | |
| Lilly USA, LLC | $40.68 | 2019-2020 | |
| Genentech USA, INC. | $38.59 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.48 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $30.23 | 2020-2021 | |
| Neurelis, INC. | $28.22 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $23.91 | 2019 | |
| Amarin Pharma, INC. | $20.01 | 2019 | |
| Shire North American Group INC | $19.32 | 2019 | |
| Neurocrine Biosciences, INC. | $15.24 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.65 | 2021 | |
| Mylan Specialty L.P. | $13.23 | 2019 | |
| Xeris Pharmaceuticals, INC. | $12.79 | 2021 | |
| Nestle Healthcare Nutrition INC. | $12.18 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Kramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.